Stay updated on Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Sign up to get notified when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.

Latest updates to the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page
- ChecktodayChange DetectedA banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” across NIH content. The clinical trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.7.0 appears on the page, marking a version update. The core trial details and user-facing content appear unchanged.SummaryDifference17%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a platform update behind the scenes and not altering the study details presented on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study's official identifiers now include the U.S. NIH grant/contract designation. This records the U.S. funding source for the trial and links the record to NIH documentation.SummaryDifference0.0%

Stay in the know with updates to Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.